Neurophysiological symptoms and aspartame: What is the connection? – PubMed

Aspartame (α-aspartyl-l-phenylalanine-o-methyl ester), an artificial sweetener, has been linked to behavioral and cognitive problems. Possible neurophysiological symptoms include learning problems, headache, seizure, migraines, irritable moods, anxiety, depression, and insomnia. The consumption of a …

Source: Neurophysiological symptoms and aspartame: What is the connection? – PubMed

Neurophysiological symptoms and aspartame

Aspartame (α-aspartyl-l-phenylalanine-o-methyl ester), an artificial sweetener, has been linked to behavioral and cognitive problems. Possible neurophysiological symptoms include learning problems, headache, seizure, migraines, irritable moods, anxiety, depression, and insomnia. The consumption of a …

Source: Neurophysiological symptoms and aspartame: What is the connection? – PubMed

see also – pubmed.ncbi.nlm.nih.gov/17684524/

 

pubmed.ncbi.nlm.nih.gov/17684524/

10 Health Benefits of Low-Carb and Ketogenic Diets

Many studies show that low-carb and ketogenic diets can lead to dramatic weight loss and improve most major risk factors for heart disease and diabetes. Also, repeatedly shown (but not always) to help with or reverse PD and other neurologicsal conditions

 

Source: 10 Health Benefits of Low-Carb an

Keto diet is a better mitochondrial therapy than ketones supplement in Parkinson’s disease

(2021). The therapeutic potential of ketone bodies in Parkinson’s disease. Expert Review of Neurotherapeutics: Vol. 21, No. 3, pp. 255-257.

Source: The therapeutic potential of ketone bodies in Parkinson’s disease

…Ketone supplementation combined with a regular carbohydrate-rich diet creates an unphysiological metabolic state that could undermine efficacy. A more promising approach may be to maintain a steady state of ketosis with a KD, while periodically boosting ketone concentration with supplementation. Progress will need to be made in developing a regimen that can be sustained for years, identifying individuals most likely to respond to ketone therapy, determining the threshold concentration for therapeutic ketosis, and managing other pharmacological treatments and social constraints. However, the bioenergetic potential of ketones and their wide-ranging pleiotropic effects indicate that ketone therapy holds considerable promise in PD and warrants further investigation.